Johnson and Johnson Agrees to Buy Swiss Synthes Inc. (SYST) for $21,5 billion

Johnson and Johnson (NYSE:JNJ), the world’s second-biggest seller of health-care products, has agreed to buy Swiss medical device manufacturer Synthes Inc. (SYST) for $21,5 billion. Johnson and Johnson will acquire Synthes for 19 billion Swiss Francs, or $21.59 billion.

Johnson & Johnson is offering 159 Swiss francs per share of the Swiss-American company, which manufactures bone implants and surgical tools. The bid is comprised of 55.65 francs in cash and 103.35 francs worth of Johnson & Johnson common strock.

View the Original article